Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults

July 12, 2021

Researchers at University of Oxford initiate phase I study of HIVconsvX vaccine

July 8, 2021

HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities

July 6, 2021

AGT103-T HIV therapeutic enters first-in-human study

May 28, 2021

Phase II trial evaluates ImmunityBio Anktiva with ART to inhibit HIV reservoirs

April 30, 2021

ViiV Healthcare presents new anti-HIV compounds

April 28, 2021

Study to assess analytical treatment interruption in participants who contracted HIV in VRC-01 trial

April 6, 2021

PGT-121 is effective without effector functions

March 19, 2021

HTI vaccines show promise for virus control without ART in patients with early HIV infection

March 17, 2021

Study indicates islatravir implants provide long-term HIV prophylaxis

March 16, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...